Corneal stromal cells selectively inhibit the production of certain anti-inflammatory cytokines

Expert Review of Clinical Immunology

Volumn 2, Issue 1, 2006, Pages 101-108

  Holán, Vladimir ^a,b  

^a INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CLODRONIC ACID; CORTICOSTEROID; CYCLOSPORIN A; FAS LIGAND; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; LEFLUNOMIDE; LIPOSOME; MESSENGER RNA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD14; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; RAPAMYCIN; SMALL INTERFERING RNA; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTERIOR EYE CHAMBER; ANTIGEN PRESENTING CELL; AQUEOUS HUMOR; CELL SELECTION; CORNEA STROMA; CORNEA TRANSPLANTATION; CYTOKINE PRODUCTION; DENDRITIC CELL; ENVIRONMENTAL EXPOSURE; EYE PROTECTION; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE PROLIFERATION; MACROPHAGE; NONHUMAN; REVIEW; STROMA CELL; T LYMPHOCYTE ACTIVATION;

EID: 33748496471     PISSN: 1744666X     EISSN: None     Source Type: Journal    
DOI: 10.1586/1744666X.2.1.101     Document Type: Review

References (52)

1. Van Dooremal JC. Die entwicklung der in fremden grund versetzten lebenden gewebe. Albrecht Van Graefes Arch. Ophthalmol. 10, 358-373 (1873).
2. Medawar PB. Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br. J. Exp. Pathol. 29, 58-69 (1948).
3. Barker CF, Billingham RE. Immunologically privileged sites. Adv. Immunol. 25, 1-54 (1977).
4. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270, 1189-1192 (1995).
5. Lee HO, Herndon JM, Barreiro R, Griffith TS, Ferguson TA. TRAIL: a mechanism of tumor surveillance in an immune privileged site. J. Immunol. 169, 4739-4744 (2002).
6. Skelsey ME, Mellon J, Niederkorn JY. Gamma delta T cells are needed for ocular immune privilege and corneal graft survival. J. Immunol. 166, 4327-4333 (2001).
7. Streilein JW, Stein-Streilein J. Does innate immune privilege exist? J. Leukoc. Biol. 67, 479-487 (2002).
8. Reinhard T, Bonig H, Mayweg S, Bohringer D, Gobel U, Sundmacher R. Soluble Fas ligand and transforming growth factor β2 in the aqueous humor of patients with endothelial immune reactions after penetrating keratoplasty. Arch. Ophthalmol. 120, 1630-1635 (2002).
9. Stein-Streilein J, Streilein JW. Anterior chamber-associated immune deviation (ACAID): regulation, biological relevance, and implication for therapy. Int. Rev. Immunol. 21, 123-152 (2002).
10. Kawashima H, Prasad SA, Gregerson DS. Corneal endothelial cells inhibit T cell proliferation by blocking IL-2 production. J. Immunol. 153, 1982-1989 (1994).
11. Wilson SE, He YG, Lloyd SA. EGF, EGF receptor, basic FGF, TGF and IL-1 messenger RNA production in human corneal epithelial cells and stromal fibroblasts. Invest. Ophthalmol. Vis. Sci. 33, 1756-1765 (1992).
12. Yan XT, Zhuang M, Oakes JE, Lausch RN. Autocrine action of IL-10 suppresses pro-inflammatory mediators and inflammation in the HSV-1-infected cornea. J. Leukoc. Biol. 69, 149-157 (2001).
13. Sonoda A, Sonoda Y, Muramatu R, Streilein JW, Usui M. ACAID induced by allogeneic corneal tissue promotes subsequent survival of orthotopic corneal grafts. Invest. Ophthalmol. Vis. Sci. 41, 790-808 (2000).
14. Holán V, Hasšková Z, Filipec M. Transplantation immunity and tolerance in the eye. Rejection and acceptance of orthotopic corneal allografts in mice. Transplantation 62, 1050-1054 (1996).
15. The Collaborative Corneal Transplantation Studies Research Group. The collaborative corneal transplantation studies (CTTS): effectiveness of histocompatibility matching in high-risk corneal transplantation. Arch. Ophthalmol. 110, 1392-1430 (1992).
16. Vitová A., Filipec M, Zajicová A, Krulová M, Holán V. Prevention of corneal allograft rejection in a mouse model of high risk recipients. Br. J. Ophthalmol. 88, 1338-1342 (2004).
17. Narayanan S, Glasser A, Hu YS, McDermott AM. The effect of interleukin-1 on cytokine gene expression by human corneal epithelial cells. Exp. Eye Res. 80, 175-183 (2005).
18. Holán V, Krulová M, Zajícová A, Pindjaková J. Nitric oxide as a regulatory and effector molecule in the immune system. Molec. Immunol. 38, 989-995 (2001).
19. Kim JC, Park GS, Kim JK, Kim YM. The role of nitric oxide in ocular surface cells. J. Korean Med. Sci. 17, 389-394 (2002).
20. Cejkova J, Ardan T, Cejka C, Kovaceva J, Zidek Z. Irradiation of the rabbit cornea with UVB rays stimulates the expression of nitric oxide synthase-generated nitric oxide and the formation of cytotoxic nitrogen-related oxidants. Histol. Histopathol. 20, 467-473 (2005).
21. O'Brien WJ, Heimann T, Tsao LS, Seet BT, McFadden G, Taylor JL. Regulation of nitric oxide synthase 2 in rabbit corneal cells. Invest. Ophthalmol. Vis. Sci. 42, 713-729 (2001).
22. Dighiero P, Behar-Cohen F, Courtois Y, Goureau O. Expression of inducible nitric oxide synthase in bovine corneal endothelial cells and keratocytes in vitro after lipopolysaccharide and cytokine stimulation. Invest. Ophthalmol. Vis. Sci. 38, 2045-2052 (1997).
23. Thakur A, Athmanathan S, Wilcox MD. The differential regulation of nitric oxide by Herpes simplex virus-1 and -2 in a corneal epithelial cell line. Clin. Exp. Ophthalmol. 28, 188-190 (2000).
24. Sagoo P, Chan G, Larkin DF, George AJ. Inflammatory cytokines induce apoptosis of corneal endothelium through nitric oxide. Invest. Ophthalmol. Vis. Sci. 45, 3964-3973 (2004).
25. Burbach GJ, Naik SM, Harten JB et al. Interleukin-18 expression and modulation in human corneal epithelial cells. Curr. Eye Res. 23, 64-68 (2001).
26. Kennedy M, Kim KH, Harten B et al. Ultraviolet irradiation induces the production of multiple cytokines by human corneal cells. Invest. Ophthalmol. Vis. Sci. 38, 2483-2491 (1997).
27. Xue ML, Wilcox MD, Lloyd A, Wakefield D, Thakur A. Regulatory role of IL-1 in the expression of IL-6 and IL-8 in human corneal epithelial cells during Pseudomonas aeruginosa colonizatrion. Clin. Exp. Ophthalmol. 29, 171-174 (2001).
28. Yamagami H, Yamagami S, Inoki T, Amano S, Miyara K. The effect of pro-inflammatory cytokines on cytokine-chemokine gene expression profiles in the human corneal endothelium. Invest. Ophthalmol. Vis. Sci. 44, 514-520 (2003).
29. Fukagawa K, Nakajima T, Saito H et al. IL-4 induces eotaxin production in corneal keratocytes but not in epithelial cells. Int. Arch. Allergy Immunol. 121, 144-150 (2000).
30. Zhang J, Xu K, Ambati B, Yu FS. Toll-like receptor 5-mediated corneal epithelial inflammatory responses to Pseudomonas aeruginosa flagellin. Invest. Ophthalmol. Vis. Sci. 44, 4247-4254 (2003).
31. Ueta M, Hamuro J, Kiyono H, Kinoshita S. Triggering of TLR3 by poly I:C in human corneal epithelial cells to induce inflammatory cytokines. Biochem. Biophys. Res. Commun. 331, 285-294 (2005).
32. Song PI, Abraham TA, Park Y et al. The expression of functional LPS receptor proteins CD14 and Toll-like receptor 4 in human corneal cells. Invest. Ophthalmol. Vis. Sci. 42, 2867-2877 (2001).
33. Ueta M, Nochi T, Jang MH et al. Intracellularly expressed TLR2s and TLR4s contribution to an immunosilent environment at the ocular mucosal epithelium. J. Immunol. 173, 3337-3347 (2004).
34. McNamara NA, Van R, Tuchin OS, Fleiszig SM. Ocular surface epithelia express mRNA for human beta defensin-2. Exp. Eye Res. 69, 483-490 (1999).
35. McDermott AM, Redfern RL, Zhang B, Pei Y, Huang L, Proske RJ. Defensin expression by the cornea: multiple signalling pathways mediate IL-1f stimulation of hBD-2 expression by human corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 44, 1859-1865 (2003).
36. Muller A, Zhang EP, Schroff M, Wittig B, Hoffmann F. Influence of ballistic gene transfer on antigen-presenting cells in murine corneas. Graefe's Arch. Clin. Exp. Ophthalmol. 240, 851-859 (2002).
37. Brissette-Storkus CS, Reynolds SM, Lepisto AJ, Hendricks RL. Identification of a novel macrophage population in the normal mouse corneal stroma. Invest. Ophthalmol. Vis. Sci. 43, 2264-2271 (2002).
38. Hamrah P, Liu Y, Zhang Q, Dana MR. The corneal stroma is endowed with a significant number of resident dendritic cells. Invest. Ophthalmol. Vis. Sci. 44, 581-589 (2003).
39. Seo SK, Gebhardt BM, Lim HY et al. Murine keratocytes function as antigen-presenting cells. Eur. J. Immunol. 31, 3318-3328 (2001).
40. Kumagai N, Fukuda K, Fujitsu Y, Lu Y, Chikamoto N, Nishida T. Lipopolysaccharide-induced expression of intercellular adhesion molecule-1 and chemokines in cultured human corneal fibroblasts. Invest. Ophthalmol. Vis. Sci. 46, 114-120 (2005).
41. Mo JS, Streilein JW. Immune privilege persists in eyes with extreme inflammation induced by intravitreal LPS. Eur. J. Immunol. 31, 3806-3815 (2001).
42. Holán V, Vitová A, Pindjaková J, Krulová M, Zajicová A, Filipec M. Corneal stromal cells selectively inhibits production of anti-inflammatory cytokines by activated T cells. Clin. Exp. Immunol. 136, 200-206 (2004).
43. van der Veen RC, Dietlin TA, Gray JD, Gilmore W. Macrophage-derived nitric oxide inhibits the proliferation of activated T helper cells and is induced during antigenic stimulation of resting T cells. Cell. Immunol. 199, 43-49 (2000).
44. Yamada J, Zhu SN, Streilein JW, Dana MR. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation. Invest. Ophthalmol. Vis. Sci. 41, 4203-4208 (2000).
45. Pleyer U, Milani JK, Dukes A et al. Effect of topically applied antiCD4 monoclonal antibodies on orthotopic corneal allografts in a rat model. Invest. Ophthalmol. Vis. Sci. 36, 52-61 (1995).
46. Klebe S, Sykes PJ, Coster DJ, Krishman R, Williams K. Prolongation of corneal sheep allograft survival by ex vivo transfer of the gene encoding interleukin-10. Transplantation 71, 1214-1220 (2001).
47. Steštiková P, Plšková J, Filipec M, Farghali H. FK 506 and aminoguanidine suppress iNOS induction in orthotopic corneal allografts and prolong graft survival in mice. Nitric Oxide 9, 111-117 (2003).
48. Siegers TP, van Roijen N, van Rij G, van der Gaag R. Delayed graft rejection in pre-vascularised corneas after subconjunctival injection of clodronate liposomes. Curr. Eye Res. 20, 322-324 (2000).
49. Siegers TP, Broersma L, van Rooijen N, Hooymans JM, van Rij G, van der Gaag R. Macrophages play a role in the early phase of corneal allograft rejection. Transplantation 77, 1641-1646 (2004).
50. Bertelmann E, Pleyer U. Immunomodulatory therapy in ophthalmology - is there a place for topical application? Ophthalmologica 218, 359-367 (2004).
51. Thakur A, Xue M, Stapleton F, Lloyd AR, Wakefield D, Willcox MD. Balance of pro- and anti-inflammatory cytokines correlates with outcome of acute experimental Pseudomonas aeruginosa keratitis. Invest. Ophthalmol. Vis. Sci. 70, 2187-2197 (2002).
52. Torres PF, Kijlstra A. The role of cytokines in corneal immunopathology. Ocular Immunol. Inflamm. 9, 9-24 (2001).